Pages that link to "Q36811927"

The following pages link to Combination diuretic treatment in severe heart failure: a randomised controlled trial (Q36811927):

Displaying 45 items.

• 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (Q22306358) (← links)
• Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload (Q33559596) (← links)
• Clinical case studies in heart failure management (Q33601339) (← links)
• Drug therapy of heart failure caused by systolic dysfunction in the elderly (Q33986297) (← links)
• Management of heart failure in the elderly (Q34493533) (← links)
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology (Q34830023) (← links)
• Clinical treatment regimens for chronic heart failure: a review (Q35000953) (← links)
• The rational use of diuretics in heart failure (Q35105848) (← links)
• Mechanisms and management of diuretic resistance in congestive heart failure (Q35143487) (← links)
• Guidelines for acute decompensated heart failure treatment (Q35675111) (← links)
• Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study (Q35826083) (← links)
• Diuretic resistance in heart failure (Q36473386) (← links)
• Simultaneous Determination and Pharmacokinetic Study of Losartan, Losartan Carboxylic Acid, Ramipril, Ramiprilat, and Hydrochlorothiazide in Rat Plasma by a Liquid Chromatography/Tandem Mass Spectrometry Method (Q36508913) (← links)
• Role of diuretics and ultrafiltration in congestive heart failure. (Q37277415) (← links)
• Acute Heart Failure Treatment (Q37291720) (← links)
• Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy (Q37408637) (← links)
• Challenges in advanced chronic heart failure: drug therapy (Q37608608) (← links)
• Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart Failure (Q37804516) (← links)
• Causes and treatment of oedema in patients with heart failure (Q38074093) (← links)
• Pharmacological treatment of acute heart failure: current treatment and new targets (Q38122297) (← links)
• Acute decompensated heart failure: evolving literature and implications for future practice. (Q38161451) (← links)
• Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy (Q38307958) (← links)
• Clinical perspectives on the rationale for potassium supplementation (Q38470687) (← links)
• Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. (Q38561441) (← links)
• A perspective on diuretic resistance in chronic congestive heart failure. (Q39448164) (← links)
• Efficacy of Intravenous Chlorothiazide for Refractory Acute Decompensated Heart Failure Unresponsive to Adjunct Metolazone. (Q39671392) (← links)
• Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships (Q41177651) (← links)
• A combined clinical and biomarker approach to predict diuretic response in acute heart failure (Q41476569) (← links)
• Combination diuretic therapy in severe congestive heart failure. (Q41722655) (← links)
• How to use diuretics in heart failure (Q43237412) (← links)
• Evidence based medical treatment of heart failure (Q43645092) (← links)
• Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis (Q46116298) (← links)
• Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure (Q46881476) (← links)
• The Initial Evaluation and Management of a Patient with Heart Failure (Q47552207) (← links)
• Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. (Q51005006) (← links)
• Simultaneous Determination and Pharmacokinetics of Metolazone, Losartan and Losartan Carboxylic Acid in Rat Plasma by HPLC-ESI-MS-MS. (Q53515317) (← links)
• ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology (Q55050673) (← links)
• Medical management of advanced heart failure (Q57396286) (← links)
• Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis (Q58127111) (← links)
• KSHF Guidelines for the Management of Acute Heart Failure: Part II. Treatment of Acute Heart Failure (Q60931782) (← links)
• Addition of a thiazide: an effective remedy for furosemide resistance after cardiac operations (Q73283417) (← links)
• Heart failure (Q74641633) (← links)
• Fluid Management in Patients with Chronic Heart Failure (Q88711578) (← links)
• Loop diuretic resistance complicating acute heart failure (Q90102824) (← links)
• Lower-Dose, Intravenous Chlorothiazide Is an Effective Adjunct Diuretic to Furosemide Following Pediatric Cardiac Surgery (Q92382215) (← links)